These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11587987)

  • 1. Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease.
    Dahl M; Tybjaerg-Hansen A; Vestbo J; Lange P; Nordestgaard BG
    Am J Respir Crit Care Med; 2001 Sep; 164(6):1008-11. PubMed ID: 11587987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: a prospective population study.
    Thomsen M; Nordestgaard BG; Vestbo J; Lange P
    Lancet Respir Med; 2013 Sep; 1(7):543-50. PubMed ID: 24461615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study.
    Garcia-Aymerich J; Lange P; Benet M; Schnohr P; Antó JM
    Am J Respir Crit Care Med; 2007 Mar; 175(5):458-63. PubMed ID: 17158282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactant protein-B 121ins2 heterozygosity, reduced pulmonary function, and chronic obstructive pulmonary disease in smokers.
    Baekvad-Hansen M; Dahl M; Tybjaerg-Hansen A; Nordestgaard BG
    Am J Respir Crit Care Med; 2010 Jan; 181(1):17-20. PubMed ID: 19833825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short telomere length, lung function and chronic obstructive pulmonary disease in 46,396 individuals.
    Rode L; Bojesen SE; Weischer M; Vestbo J; Nordestgaard BG
    Thorax; 2013 May; 68(5):429-35. PubMed ID: 23268483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetically increased antioxidative protection and decreased chronic obstructive pulmonary disease.
    Juul K; Tybjaerg-Hansen A; Marklund S; Lange P; Nordestgaard BG
    Am J Respir Crit Care Med; 2006 Apr; 173(8):858-64. PubMed ID: 16399992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic obstructive pulmonary disease and hospitalizations for pneumonia in a US cohort.
    Mannino DM; Davis KJ; Kiri VA
    Respir Med; 2009 Feb; 103(2):224-9. PubMed ID: 18945605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and biochemical markers of obstructive lung disease in the general population.
    Dahl M
    Clin Respir J; 2009 Apr; 3(2):121-2. PubMed ID: 20298391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study.
    Prescott E; Bjerg AM; Andersen PK; Lange P; Vestbo J
    Eur Respir J; 1997 Apr; 10(4):822-7. PubMed ID: 9150319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study.
    Watson L; Vonk JM; Löfdahl CG; Pride NB; Pauwels RA; Laitinen LA; Schouten JP; Postma DS;
    Respir Med; 2006 Apr; 100(4):746-53. PubMed ID: 16199147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes in mild/moderate chronic obstructive pulmonary disease in the European community respiratory health survey.
    de Marco R; Accordini S; Antò JM; Gislason T; Heinrich J; Janson C; Jarvis D; Künzli N; Leynaert B; Marcon A; Sunyer J; Svanes C; Wjst M; Burney P
    Am J Respir Crit Care Med; 2009 Nov; 180(10):956-63. PubMed ID: 19696441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease.
    Thomsen M; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    Am J Respir Crit Care Med; 2012 Nov; 186(10):982-8. PubMed ID: 22983959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels.
    Wedzicha JA; Seemungal TA; MacCallum PK; Paul EA; Donaldson GC; Bhowmik A; Jeffries DJ; Meade TW
    Thromb Haemost; 2000 Aug; 84(2):210-5. PubMed ID: 10959691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma markers of inflammation and incidence of hospitalisations for COPD: results from a population-based cohort study.
    Engström G; Segelstorm N; Ekberg-Aronsson M; Nilsson PM; Lindgärde F; Löfdahl CG
    Thorax; 2009 Mar; 64(3):211-5. PubMed ID: 18988660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden--the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study.
    Danielsson P; Ólafsdóttir IS; Benediktsdóttir B; Gíslason T; Janson C
    Clin Respir J; 2012 Apr; 6(2):120-7. PubMed ID: 21651748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of smoking-related hyperhomocysteinemia on spirometric declines in chronic obstructive pulmonary disease in elderly Japanese.
    Kai S; Nomura A; Morishima Y; Ishii Y; Sakamoto T; Hegab AE; Sekizawa K
    Arch Gerontol Geriatr; 2006; 42(2):117-24. PubMed ID: 16125804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk factors of chronic obstructive pulmonary disease in patients with chronic bronchitis].
    Xie G; Cheng X; Xu X
    Zhonghua Yi Xue Za Zhi; 2001 Nov; 81(22):1356-9. PubMed ID: 11930627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender and chronic obstructive pulmonary disease in high-risk smokers.
    de Torres JP; Campo A; Casanova C; Aguirre-Jaime A; Zulueta J
    Respiration; 2006; 73(3):306-10. PubMed ID: 16330871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is TNF-α gene polymorphism related to pulmonary functions and prognosis as determined by FEV1, BMI, COPD exacerbation and hospitalization in patients with smoking-related COPD in a Turkish population?
    Özdoğan N; Tutar N; Demir R; Saatçi Ç; Kanbay A; Büyükoğlan H
    Rev Port Pneumol; 2014; 20(6):305-10. PubMed ID: 24818527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.